Biography

Dr. Mitnick is Professor of Global Health & Social Medicine at Harvard Medical School. She has worked for more than 25 years to increase access to high-quality, appropriate treatment for TB, especially for drug-resistant TB. Together with collaborators and mentees around the world, she leverages research, training, policy, programmatic support, activism, and advocacy to advance global health equity. Her research includes multi-country clinical trials and observational studies of novel treatments for rifampin-resistant TB. She also works to improve our understanding of post-TB lung impairment: the scale of the problem, how people experience it, and how to care for them.

Expertise

TB Diagnostics
Public Health

Key Impacts

When are uncontrolled trials in TB scientifically and ethically justified: Borrowing wisdom from early AIDS clinical trials

Impact details available upon request.

Source: Conference 2024